Sec. 206. Grant program on harms of drug misuse
321 words·~1 min read·
/bill/117/hr/2366/ih/section-206·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Assistant Secretary for Mental Health and Substance Use (referred to in this section as the Assistant Secretary ), in consultation with the Director of the Centers for Disease Control and Prevention, shall award grants to States, political subdivisions of States, Tribes, Tribal organizations, and community-based entities to support the delivery of overdose prevention, syringe services programs, and other harm reduction services that address the harms of drug misuse, including by— preventing and controlling the spread of infectious diseases, such as HIV/AIDS and viral hepatitis, and the consequences of such diseases for individuals with substance use disorder; distributing opioid antagonists, such as naloxone, to individuals at risk of overdose; connecting individuals at risk for, or with, a substance use disorder to overdose education, counseling, and health education; and encouraging such individuals to take steps to reduce the negative personal and public health impacts of substance use or misuse.
In awarding grants under this section, the Assistant Secretary shall prioritize grants to applicants that are— culturally specific organizations, Tribal behavioral health and substance use disorder providers, or organizations that are intentional about serving populations where COVID–19 has had the most impact; or proposing to serve areas with— a higher proportion of the population who meet criteria for dependence on, or abuse of, illicit drugs; a higher drug overdose death rate; a greater telemedicine infrastructure need; and a greater behavioral health and substance use disorder workforce need.
A recipient of a grant under this section may use such grant funds for the following purposes: Adapt, maintain, and expand essential services provided by harm reduction service organizations to address the risks of COVID–19, drug overdose, and contraction of infectious disease. Maintain or hire staff. Support program operational costs, including staff, rent, and vehicle purchase or maintenance. Program supplies. Support and case management services. To carry out this section, there is authorized to be appropriated $50,000,000 for fiscal year 2022, to remain available until expended.